Search research articles
Contact Us
Filters
Showing results (151-160 of 155) with videos related to
Page
of 16
Sort By:
You have reached the last page of results.
This site can display upto 155 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Jörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2014
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Franck Bonnetain, Bert Bonsing, Thierry Conroy, et al.
Clinical Trials (London, England)
|
August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials
Andrew Bottomley, Madeline Pe, Jeff Sloan, et al.
The Lancet. Oncology
|
November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
Andrew Bottomley, Madeline Pe, Jeff Sloan, et al.
The Lancet. Oncology
|
August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
David Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
Page
of 16
Search research articles
Search
Showing results (151-160 of 155) with videos related to
Sort By:
Page
of 16
You have reached the last page of results.
This site can display upto 155 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
Jörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2014
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Franck Bonnetain, Bert Bonsing, Thierry Conroy, et al.
Clinical Trials (London, England)
|
August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials
Andrew Bottomley, Madeline Pe, Jeff Sloan, et al.
The Lancet. Oncology
|
November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards
Andrew Bottomley, Madeline Pe, Jeff Sloan, et al.
The Lancet. Oncology
|
August 4, 2023
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups
David Pasquier, Luc Bidaut, Daniela Elena Oprea-Lager, et al.
Page
of 16